![]() |
![]() |
|
|
Forward to a colleague |
||
Access Full Stories Pfizer has inked an "innovative" research pact with St Louis-based Washington University to the tune of $25m... Read Administrators attempting to sell UK's Jaycare Administrators are now trying to sell Jaycare, a UK custom manufacturer and supplier of rigid plastic packaging, medical devices and technical componentry to the pharma and healthcare industries, which has gone... Read PPD initiates central lab services in China Pharmaceutical Product Development (PPD) has initiated central laboratory services in China in response to the country's budding clinical trials scene... Read Parexel posts impressive Q2 profits Parexel has reported positive financial results for the second quarter of 2008... Read WaferGen pushes PCR research with Malaysian subsidiary WaferGen has launched a new subsidiary in Kedah, Malaysia, with the express purpose of overseeing research and development of its real-time PCR system... Read |
|||||||||||||||||
All News Headlines for: January | December | November |
|||||||||||||||||
![]() DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here | |||||||||||||||||
|
Related Industry News New Alzheimer's theory gains NASA backing A controversial new theory on the origins of Alzheimer's has divided opinion in the medical world, but if proved right could 'revolutionise' treatment... Read SOS: save our solvent! In any laboratory, or indeed in any pharmaceutical manufacturing facility, one of the major expenses will be solvents. And just like the price of petrol and diesel it just keeps going up and up. Huw Kidwell examines... Read Acquisitions pay off for Novozymes ingredients in 2007 The small but fast-growing biopharmaceutical ingredients (BPI) business of Denmark's Novozymes, the leading manufacturer of industrial enzymes worldwide, delivered a strong performance in 2007, with sales rising... Read Teva jumps on biologics bandwagon with $400m buy Israeli generics behemoth Teva is following the market and banking on the promise of biologics with its purchase of Human Genome Sciences biotech spin-off, CoGenesys... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||